NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research. Earlier ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and ...

ZAHRA HAGHIGHAT, M.D., is a child neurologist specializing in epilepsy care at UK HealthCare’s Level IV Epilepsy Center.

Q3 2024 Earnings Call Transcript November 5, 2024 Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.8. Operator: Good day, and thank you for ...

Welcome to the third-quarter 2024 Novo Nordisk A/S earnings conference call. [Operator instructions] Please be advised that ...

Tetanus is a serious bacterial infection caused by Clostridium tetani, which affects the nervous system, leading to muscle stiffness and spasms. With an increased awareness of disease prevention, ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal ...

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.

Amber Hill spent 14 years as a medical researcher. She didn't mind the work, but there was one thing she consistently hated: ...

Health and Human Services should next consider funding for grandma’s chicken soup.

A trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists' understanding of how small DNA circles -; until recently dismissed as ...